Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,848.00
+61.00 (3.41%)
At close: Jul 31, 2025
3.41%
Market Cap17.14B
Revenue (ttm)1.00B
Net Income (ttm)-13.37B
Shares Out9.28M
EPS (ttm)-1,637.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,646
Average Volume1,993
Open1,795.00
Previous Close1,787.00
Day's Range1,711.00 - 1,860.00
52-Week Range680.00 - 3,300.00
Beta0.14
RSI44.06
Earnings Daten/a

About ROIC

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy. The company was founded in 2015 and is based in Seongnam, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.